NCT03115528

Brief Summary

Objectives: Primary Objective: The primary objective is to identify the difference in the estimation of prognosis of advanced cancer patients between medical oncologists, gynecological oncologists, and palliative care physicians

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
54mo left

Started Dec 2017

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Dec 2017Dec 2030

First Submitted

Initial submission to the registry

April 6, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

December 14, 2017

Completed
13 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

May 22, 2019

Status Verified

May 1, 2019

Enrollment Period

13 years

First QC Date

April 6, 2017

Last Update Submit

May 20, 2019

Conditions

Keywords

Malignant neoplasms of independent (primary) multiple sitesMedical oncologistsPalliative care physiciansQuestionnaireSurvey

Outcome Measures

Primary Outcomes (1)

  • Estimation of Patient Overall Survival by Oncologists and by Palliative Care Physicians per Estimation of Prognosis Questionnaire

    The answer to the question #4, "How long do you think this patient will live?" in the questionnaire is the primary endpoint. Denoting the oncologist estimated OS time from the day of palliative care consult to death by TOnc, palliative care physician estimate by TPalliative, and the true OS time by T0, we define the accuracy of the estimation of OS by oncologists and by palliative care physician as ΔOnc = TOnc - T0 ΔPalliative = TPalliative - T0. And the difference between these two estimates is calculated as ΔOS = ΔOnc - ΔPalliative. Based on the above formulas, ΔOS is actually calculated as (TOnc- TPalliative). The true survival time, T0, is cancelled out by the subtraction.

    6 weeks

Study Arms (2)

Medical Oncology Physicians

Medical oncology physicians are sent the Estimation of Prognosis questionnaire by email.

Behavioral: Estimation of Prognosis Questionnaire

Palliative Care Physicians

Palliative care physicians are sent the Estimation of Prognosis questionnaire by email.

Behavioral: Estimation of Prognosis Questionnaire

Interventions

Survey will examine two aspects of prognosis estimation: 1.) physician factors, 2.) prognosis estimation and contributing factors to patient prognosis. Survey will take approximately 5 minutes to complete.

Also known as: Survey
Medical Oncology PhysiciansPalliative Care Physicians

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Medical oncologists and palliative care physicians from UT MD Anderson Cancer Center

You may qualify if:

  • Medical oncologists or gynecological who referred patients to the palliative care team; Palliative Care physicians to whom the patients were referred; Patients with locally advanced, metastatic, or, not curable cancer.
  • years old or older

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Angelique N. Wong, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2017

First Posted

April 14, 2017

Study Start

December 14, 2017

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

May 22, 2019

Record last verified: 2019-05